Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines

CAMBRIDGE, Mass. & SAN DIEGO–(BUSINESS WIRE)–Be Biopharma and National Resilience today announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline.
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks